MedPath

Roxime

Brand Name: Roxime

Generic Name: Cefuroxime (as Sodium)

Active
Registration Number

DRP-2018

Dosage Form

Powder for Injection (IM/IV)

Issuance Date

January 31, 2022

Expiry Date

February 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength750mg
PackagingUSP Type III Glass Vial (Box of 10's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antibacterial (Cephalosporin)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cefuroxime (as Sodium)Active
Monograph: cefuroxime (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.